Trial Profile
Effect of Abaloparatide on Lumbar Disc Degeneration
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Abaloparatide (Primary)
- Indications Back pain
- Focus Proof of concept; Therapeutic Use
- 07 Apr 2021 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 13 May 2020 Planned End Date changed from 1 Feb 2023 to 1 Feb 2024.
- 13 May 2020 Planned primary completion date changed from 1 Aug 2022 to 1 Aug 2023.